Medmix AG (XSWX:MEDX) EBIT : CHF13.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medmix AG EBIT?

Medmix AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was CHF-0.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF13.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medmix AG's annualized ROC % for the quarter that ended in Dec. 2023 was 0.57%. Medmix AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -0.14%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medmix AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.55%.

Medmix AG EBIT Historical Data

The historical data trend for Medmix AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medmix AG EBIT Chart

Medmix AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

38.20

18.20

59.40

18.60

13.00

Medmix AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial					28.00	16.70	1.90	13.20	-0.20

Competitive Comparison of Medmix AG's EBIT

For the Specialty Industrial Machinery subindustry, Medmix AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medmix AG's EV-to-EBIT Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Medmix AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medmix AG's EV-to-EBIT falls into.

Medmix AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF13.0 Mil.

Medmix AG (XSWX:MEDX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medmix AG's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	4 * ( 1 - -8.2% )	/	( (727.9	+	793.8)	/ 2 )
=	4.328	/	760.85
=	0.57 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	971.6	-	91	-	( 152.7	-	max(0, 147.6	-	340.4	+	152.7	))
=	727.9

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1006.8	-	83	-	( 130.6	-	max(0, 178.1	-	308.1	+	130.6	))
=	793.8

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Medmix AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.4	/	( ( (251 + max(29.8, 0))	+	(258.1 + max(39.6, 0)) )	/	2 )
=	-0.4	/	( ( 280.8	+	297.7 )	/	2 )
=	-0.4	/	289.25
=	-0.14 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(66.6	+	97.4	+	3.4)	-	(91	+	0	+	46.6)
=	29.8

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(56.8	+	88.4	+	30.3)	-	(83	+	0	+	52.9)
=	39.6

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medmix AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	13	/	839.800
	=	1.55 %

Medmix AG EBIT Related Terms

Thank you for viewing the detailed overview of Medmix AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Medmix AG (XSWX:MEDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Medmix AG (XSWX:MEDX) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

MDMXF:USA MEDXz:UK

Address

Dammstrasse 19, Baar, Zug, CHE, 6340

Website

https://www.medmix.swiss

Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of revenue is from Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas and Asia-Pacific.